Cytokinetics (CYTK) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free CYTK Stock Alerts $64.80 -2.02 (-3.02%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCytokinetics to Announce First Quarter Results on May 8, 2024globenewswire.com - April 24 at 4:00 PMHealthInvest Partners AB Buys Shares of 11,733 Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - April 16 at 6:50 PMCytokinetics (NASDAQ:CYTK) Trading Up 3.4%marketbeat.com - April 16 at 3:23 PMLouisiana State Employees Retirement System Invests $4.10 Million in Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - April 15 at 7:32 AMCytokinetics, Incorporated (NASDAQ:CYTK) Sees Large Decline in Short Interestamericanbankingnews.com - April 15 at 4:14 AMCytokinetics to present phase 3 trial results for heart drug at Heart Failure 2024uk.investing.com - April 11 at 11:56 PMCytokinetics EVP sells over $2.4m in company stockuk.investing.com - April 11 at 1:55 PMDekaBank Deutsche Girozentrale Acquires 20,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - April 11 at 5:58 AMMoody Aldrich Partners LLC Lowers Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - April 10 at 8:54 AMCytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congressglobenewswire.com - April 10 at 7:30 AMCytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congressglobenewswire.com - April 10 at 7:30 AMCytokinetics, Incorporated (NASDAQ:CYTK) EVP Sells $2,422,877.55 in Stockinsidertrades.com - April 10 at 4:53 AMEVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)finance.yahoo.com - April 9 at 9:14 PMFady Ibraham Malik Sells 32,605 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) Stockmarketbeat.com - April 9 at 6:30 PMPeregrine Capital Management LLC Sells 73,150 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - April 9 at 3:30 PMCytokinetics' (CYTK) Buy Rating Reaffirmed at Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMCytokinetics (NASDAQ:CYTK) Receives "Buy" Rating from Truist Financialmarketbeat.com - April 8 at 11:37 AMBuy Rating Affirmed for Cytokinetics Amid Strong Aficamten Trial Resultsmarkets.businessinsider.com - April 5 at 8:00 PMBuy Rating Affirmed on Cytokinetics Amid Promising Aficamten Clinical Resultsmarkets.businessinsider.com - April 5 at 8:00 PMCytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Sessionglobenewswire.com - April 5 at 7:30 AM$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Todaybenzinga.com - April 3 at 6:41 PMCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 2 at 4:00 PMCytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - April 2 at 4:22 AMCytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 1 at 4:00 PMCytokinetics, Incorporated: Buyout Speculation Persistsseekingalpha.com - April 1 at 6:08 AMCYTK Apr 2024 60.000 callfinance.yahoo.com - March 30 at 11:29 PMVanguard Group Inc. Buys 472,595 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - March 28 at 4:23 AMCytokinetics gains amid renewed takeover speculationmsn.com - March 27 at 8:54 AMAssenagon Asset Management S.A. Takes Position in Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - March 26 at 2:55 PMCytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Sessionglobenewswire.com - March 25 at 8:15 AMLegato Capital Management LLC Takes $1.31 Million Position in Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - March 24 at 1:43 PMCytokinetics, Incorporated (NASDAQ:CYTK) Sees Large Increase in Short Interestmarketbeat.com - March 19 at 9:20 PMCytokinetics (NASDAQ:CYTK) Trading 7.4% Higher marketbeat.com - March 19 at 4:52 PM7 Biotech Stocks Ready to Ride the Sector's Resurgenceinvestorplace.com - March 18 at 8:01 PMCYTK Mar 2024 63.000 callfinance.yahoo.com - March 16 at 7:00 PMHudson Bay Capital Management LP Buys 60,000 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - March 16 at 5:51 AMCYTK Mar 2024 69.000 putfinance.yahoo.com - March 15 at 8:19 PMCYTK Mar 2024 69.000 callfinance.yahoo.com - March 15 at 8:19 PMWellington Management Group LLP Trims Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)marketbeat.com - March 15 at 6:43 AMAnalysts Conflicted on These Healthcare Names: Amedisys (AMED), Cytokinetics (CYTK) and Coherus Biosciences (CHRS)markets.businessinsider.com - March 15 at 12:16 AMCYTK Mar 2024 62.000 callfinance.yahoo.com - March 15 at 12:16 AMCYTK Apr 2024 58.000 putfinance.yahoo.com - March 15 at 12:16 AMBuy Rating Affirmed for Coherus Biosciences on Strong Sales and Strategic Restructuringmarkets.businessinsider.com - March 14 at 2:16 PM15,944 Shares in Cytokinetics, Incorporated (NASDAQ:CYTK) Purchased by Neo Ivy Capital Managementmarketbeat.com - March 14 at 6:30 AM7 Biotech Stocks to Buy as Sector Rotation Ramps Upinvestorplace.com - March 13 at 2:25 PMIonis stock jumps as MASH drug succeeds in mid-stage trialseekingalpha.com - March 13 at 9:39 AMCYTK Aug 2024 30.000 putca.finance.yahoo.com - March 12 at 12:19 PMCYTK Mar 2024 61.000 putfinance.yahoo.com - March 12 at 12:19 PMQ4 2023 CytomX Therapeutics Inc Earnings Callfinance.yahoo.com - March 12 at 7:17 AMCYTK Apr 2024 65.000 putfinance.yahoo.com - March 11 at 1:02 PM Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. CYTK Media Mentions By Week CYTK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTK News Sentiment▼0.360.41▲Average Medical News Sentiment CYTK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTK Articles This Week▼26▲CYTK Articles Average Week Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Viking Therapeutics News Cerevel Therapeutics News Jazz Pharmaceuticals News Elanco Animal Health News Intra-Cellular Therapies News Apellis Pharmaceuticals News Ascendis Pharma A/S News Ionis Pharmaceuticals News Legend Biotech News Blueprint Medicines News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTK) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
